A Biotech Breakthrough?
Podcast |
MarketFoolery
Publisher |
The Motley Fool
Media Type |
audio
Categories Via RSS |
Business
Business News
News
Publication Date |
Oct 22, 2019
Episode Duration |
00:19:03

Biogen rises on news that it plans to file for FDA approval of its Alzheimers drug, Aducanumab. Under Armour gets a new CEO. And Hasbro tumbles on tariff trouble. Motley Fool analysts Andy Cross and Ron Gross tackle those stories and weigh in on the relative merits of Monopoly and Mr. Potato Head.

Thanks to Molekule for supporting our channel.  Get 10% off your first air purifier at http://www.molekule.com with code fool10.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review